Table 2 Correlations between selected clinical, laboratory and functional data and NT-proCNP levels in COPD patients.
From: NT-proCNP as a new biomarker of pulmonary hypertension in patients with COPD
Variable | Correlation coefficient | P value |
---|---|---|
Age, years | 0.05 | 0.67 |
mMRC, points | 0.42 | 0.001 |
CAT, points | 0.60 | < 0.001 |
FEV1, % predicted | − 0.40 | 0.001 |
FVC, % predicted | − 0.22 | 0.08 |
FEV1/FVC, % | − 0.12 | 0.24 |
SpO2, % | − 0.47 | 0.001 |
6-MWD, m | − 0.30 | 0.004 |
Fibrinogen, mg/L | 0.45 | 0.001 |
CRP, mg/L | 0.46 | 0.001 |
SPAP, mmHg | 0.77 | < 0.001 |